Ignite Creation Date:
2024-05-06 @ 4:22 PM
Last Modification Date:
2024-10-26 @ 2:09 PM
Study NCT ID:
NCT04963088
Status:
UNKNOWN
Last Update Posted:
2021-07-15
First Post:
2021-06-21
Brief Title:
TISLELIZUMAB Combined With Anlotinib and ChemotherapyXELOX in the Treatment of Advanced Gastric Carcinoma
Sponsor:
Organization:
The First Affiliated Hospital with Nanjing Medical University